GS-441524 is the main plasma metabolite of the antiviral prodrug remdesivir, and has a half-life of around 24 hours in human patients. Remdesivir and GS-441524 were both found to be effective in vitro against feline coronavirus strains responsible for feline infectious peritonitis (FIP), a lethal systemic disease affecting domestic cats.
| Attribute | Value |
|---|---|
| Packaging | 5.5ml/vial, 6ml/vial, 8ml/vial, 10ml/vial, |
| Availability | Available |
| Shelf Life | 12 Months |
| Product Name | GS-441524 Injection |
| Storage | 2-20°C |
| Indication | Treatment of Cat FIP |
| Active Ingredient | GS-441524 |
| Country of Manufacture | China |
| Dosage Form | Solution |
Recommended dosage:*DOSAGE IS BASED ON THE WEIGHT AND SYMPTOMS*
Ascites / pleural effusion: 0.5mL/kg * body weight kg + 0.1 residue
FIP(Wet):0.4mL/kg * body weight kg + 0.1 residue
FIP(Dry): 0.6mL/kg * body weight kg + 0.1 residue
Eye / nerve entry: 0.7mL/kg * body weight kg + 0.1 residue
Recurrence: 0.9 mL/ kg * body weight kg + 0.1 residue
